Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cord Blood Serum Eye Drops for EGFR-Inhibitor Induced Dry Eye
NCT06830551Recruiting
- Sponsor
- Sant'Orsola-Malpighi University Hospital
- Start
- Sep 2023
- Primary completion
- Dec 2025
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
Open-label, single-arm trial of human umbilical cord blood serum in dry eye syndrome (DED), sponsored by Sant'Orsola-Malpighi University Hospital. Primary endpoint: Corneal damage measured with National Eye Institute (NEI) score. Started Sep 2023; status: recruiting.
02
Drugs
human umbilical cord blood serum
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on NCT06830551.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06830551.